Shandong Buchang Pharmaceuticals' share price and EPS declin...

Shandong Buchang Pharmaceuticals' share price and EPS decline over the past three years hint at ongoing challenges. The company's underperformance compared to the broader market over the past year may suggest unresolved issues. Investors should consider market conditions and other key factors.